milepoint.

Looking to expand or launch outside of Europe: Insights into approaching the US market. 👉 This insightful session of #MedFIT2023 addressed the significant challenges and opportunities that MedTech companies encounter when looking to expand or launch in the United States. Many companies initially focus on their home markets, but the US market offers unique dynamics that require a strategic approach. 🎤 Many thanks to our talented speakers: • Charlotte Puechmaille, Kranus Health • Przemek Czerklewicz, milepoint. • Haider Alleg, Allegory Capital • Arjan van Manen, SkylineDx BV • Matthieu Leclerc-Chalvet, Therapixel Marion Loizurot Jules ADAM Yingjie WENG

Overheard on discussion panels at MedFIT Event - Day #2 Wonder if you recognize your insights 😉 - Carole Absil, Nayeli Schmutz, Ryan Ramkhelawan, Anna Erat (MD, PhD, IDP INSEAD), Charlotte Puechmaille, Przemek Czerklewicz, Haider ALLEG, Arjan van Manen, Matthieu Leclerc-Chalvet, Artur Olesch, Kristine Morrill, Jessica Garestier, Thom Rasche Great discussions in the panels and beyond. Thank you for sharing your experience and thoughts. We need more of that!

Today we're in Strasbourg🇫🇷 for #MedFIT2023, an event with key innovators in the #MedTech, Diagnostic and #DigitalHealth sectors organised by our French member and ecosystem Eurasanté. ECHAlliance is a partner of the event. Our Communities Manager Adriana Díaz Martín-Zamorano has moderated a panel debate on how to fund early-stage medtech starts-ups in Europe with 🔝 speakers: Esther Reynal de St Michel Richardot (THENA Capital), Cyril Teixeira da Silva (European Investment Bank (EIB)), Jan Engels (HTGF | High-Tech Gründerfonds), Laura Achach (Kurma Partners) and Nina Lameule (NLC - The European Healthtech Venture Builder). MedFIT Event has also been a great opportunity to meet some ECHAlliance members such as milepoint. led by Przemek Czerklewicz🤝

📆 On Tuesday 10th october from 2.00 to 3.30 pm, Edouard Gasser is invited at MedFIT Event to share his knowledge during the Toolbox session: « Getting a digital therapeutic approved and reimbursed in Europe », along Przemek Czerklewicz (milepoint.), Vincent Vercamer (Ministère de la Santé), Jörg Trinkwalter (ProCarement GmbH) and Kathrin Pfeiffer (Sympatient). Moderator : Anish Shindore. 🎤 📑 The EU describes Digital Therapeutics (DTx) as “evidence-based therapeutic interventions driven by software to prevent, manage, or treat a medical disease.” 👉 DTx are increasingly recognised and adopted into national frameworks worldwide to improve patient care: they can now be prescribed, opening new business model for digital health applications. However, they must first be approved for reimbursement, with no specific regulation existing at EU level. Drawing inspiration from the German DiGA Fast Track, France and Belgium have also taken steps to implement reimbursement processes for DTx. Thus, approval rules for DTx are being created by single countries, resulting into a fragmentation in terms of requirements and regulatory standards.   To follow his speech, go to ➡️ https://lnkd.in/ePCJzR4

📑 The EU describes Digital Therapeutics (DTx) as “evidence-based therapeutic interventions driven by software to prevent, manage, or treat a medical disease.”  👉 DTx are increasingly recognised and adopted into national frameworks worldwide to improve patient care: they can now be prescribed, opening new business model for digital health applications. However, they must first be approved for reimbursement, with no specific regulation existing at EU level. Drawing inspiration from the German DiGA Fast Track, France and Belgium have also taken steps to implement reimbursement processes for DTx. Thus, approval rules for DTx are being created by single countries, resulting into a fragmentation in terms of requirements and regulatory standards. 🎤 Przemek Czerklewicz (milepoint.), Vincent Vercamer (Ministère de la Santé), Jörg Trinkwalter (ProCarement GmbH), Kathrin Pfeiffer (Sympatient) and Edouard Gasser (Tilak Healthcare) will share their insights on DTx at #MedFIT2023 during the session titled: "Getting a digital therapeutic approved and reimbursed in Europe" on Tuesday, October 10th from 2.00 to 3.30 pm. Discover the whole conference programme here > https://lnkd.in/eSdcKH_Q Marion Loizurot | Mathilde Wozniak | Yingjie WENG